Search Site


Answer Centre - Telephone Answering in your Company Name by an Answer Centre PA


Sinclair licenses Sebclair to Dr Reddy’s in the US

27 September 2007

Sinclair Pharma has licensed the exclusive US rights of its seborrheic dermatitis product, Sebclair to Dr Reddy's Laboratories Inc.. Dr. Reddy's will market the product under a new brand name through its new dermatology division.

Under the agreement Sinclair will receive certain milestone payments over the agreement period. Upon commercialisation of the product, Sinclair will receive royalty payments based on net sales.

Dr Michael Flynn, chief executive of Sinclair Pharma, said: “This exciting new deal for Sinclair means that Sebclair is now entering the start of its commercial life. Dr Reddy's has a strong global presence and we believe that Sebclair represents an opportunity to support their ambitions for the US dermatology sector.”

Earlier this week, Sinclair announced UK launches for its Atopiclair Cream for Atopic Dermatitis (eczema) and Xclair Cream for radiation dermatitis (skin damage during radiotherapy).






Headlines

31 August 2010

30 August 2010

27 August 2010

20 August 2010

18 August 2010

13 August 2010

09 August 2010

06 August 2010

30 July 2010

29 July 2010

28 July 2010

27 July 2010

26 July 2010

23 July 2010

23 July 2010

22 July 2010

21 July 2010

19 July 2010

16 July 2010

12 July 2010

09 July 2010

08 July 2010

07 July 2010

06 July 2010

05 July 2010

02 July 2010

06 May 2010

13 April 2010

24 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

23 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

22 March 2010

19 March 2010

19 March 2010

» See all News




© SmallCapNews   |   Contact Us   |   Terms of Use   |   RSS Feeds Site by LunarSafari